Temporal alterations and cellular mechanisms of transmural repolarization during progression of mouse cardiac hypertrophy and failure

被引:25
作者
Shi, C. [1 ,2 ]
Wang, X. [3 ]
Dong, F. [1 ,2 ]
Wang, Y. [1 ,2 ]
Hui, J. [1 ,2 ]
Lin, Z. [1 ,2 ]
Yang, J. [1 ,2 ]
Xu, Y. [1 ,2 ]
机构
[1] Hebei Med Univ, Key Lab Neural & Vasc Biol, Minist Educ, Dept Pharmacol, Shijiazhuang 050017, Peoples R China
[2] Hebei Med Univ, Key Lab New Drug Pharmacol & Toxicol, Dept Pharmacol, Shijiazhuang 050017, Hebei Province, Peoples R China
[3] Hebei Med Univ, Hosp 3, Shijiazhuang 050017, Peoples R China
基金
中国国家自然科学基金;
关键词
cardiac hypertrophy; heart failure; L-type calcium channel; mouse; potassium channels; transmural dispersion of repolarization; RAT LEFT-VENTRICLE; K+ CURRENTS; MODEL; CA2+; EXPRESSION; CONDUCTION; DISPERSION; DEATH; ARRHYTHMOGENESIS; DEPOLARIZATION;
D O I
10.1111/apha.12071
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Aim The remodelling of transmural dispersion of repolarization (TDR) in human heart failure (HF) and in different animal models of cardiac hypertrophy or HF remains a controversial topic. We hypothesize that TDR may exhibit temporal alterations, depending on the stage of the disease. Methods We systematically investigated the temporal alterations of TDR during the development of cardiac hypertrophy and HF in the mouse pressure-overload model using electrophysiological and molecular biology techniques. Results A progressive prolongation of QT interval and changes in the amplitude of the J wave at 2, 5, 9 and 13 weeks were found in anesthetized aorta-banded mice. Action potential duration (APD) at 90% repolarization (APD90) in subendocardial myocytes of the left ventricular free wall remained unchanged at the hypertrophic stage (2 and 5weeks), but was significantly prolonged in HF mice at 9 and 13weeks. However, APD90 in subepicardial myocytes exhibited a significant prolongation at 2weeks and did not progressively extend from 2weeks to 13weeks in banded mice. Thus, non-parallel prolongation of APD in subendocardial and subepicardial myocytes led to a reduction in TDR at hypertrophic stage and an amplification of TDR at HF stage. Further experiments revealed that asynchronous down-regulation of voltage-dependent potassium currents (Ito,f, IK,slow and Iss) and L-type calcium currents (ICa-L) in subendocardial and subepicardial myocytes may contribute to the dynamic remodelling of transmural APD. Conclusion The two distinct TDR modes were revealed during the progression of mouse cardiac hypertrophy and failure, indicating that the remodelling of TDR depends on the stage of the disease.
引用
收藏
页码:95 / 110
页数:16
相关论文
共 50 条
  • [21] Alterations in ionic currents and relation to contractile dysfunction with severe cardiac hypertrophy and failure
    Mukherjee R.
    Spinale F.G.
    Heart Failure Reviews, 1999, 4 (4) : 319 - 327
  • [22] Sex-dependent alterations of Ca2+ cycling in human cardiac hypertrophy and heart failure
    Fischer, Thomas H.
    Herting, Jonas
    Eiringhaus, Joerg
    Pabel, Steffen
    Hartmann, Nico H.
    Ellenberger, David
    Friedrich, Martin
    Renner, Andre
    Gummert, Jan
    Maier, Lars S.
    Zabel, Markus
    Hasenfuss, Gerd
    Sossalla, Samuel
    EUROPACE, 2016, 18 (09): : 1440 - 1448
  • [23] Imperatorin prevents cardiac hypertrophy and the transition to heart failure via NO-dependent mechanisms in mice
    Zhang, Yan
    Cao, YanJun
    Duan, HaiJie
    Wang, Hongying
    He, LangChong
    FITOTERAPIA, 2012, 83 (01) : 60 - 66
  • [24] Preventing progression of cardiac hypertrophy and development of heart failure by paricalcitol therapy in rats
    Bae, Soochan
    Yalamarti, Bhargavi
    Ke, Qingen
    Choudhury, Sangita
    Yu, Hyeon
    Karumanchi, S. Ananth
    Kroeger, Paul
    Thadhani, Ravi
    Kang, Peter M.
    CARDIOVASCULAR RESEARCH, 2011, 91 (04) : 632 - 639
  • [25] PLASTICITY OF MYOCARDIAL PHENOTYPE DURING CARDIAC-HYPERTROPHY AND FAILURE
    MERCADIER, JJ
    LOMPRE, AM
    SWYNGHEDAUW, B
    SCHWARTZ, K
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 1993, 177 (06): : 917 - 933
  • [26] Vascular alterations during the development and progression of experimental heart failure
    Crespo, MJ
    JOURNAL OF CARDIAC FAILURE, 1999, 5 (01) : 55 - 63
  • [27] Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure
    Gupta, Mahesh P.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2007, 43 (04) : 388 - 403
  • [28] Impact of polyphenols on heart failure and cardiac hypertrophy: clinical effects and molecular mechanisms
    Hedayati, Neda
    Yaghoobi, Alireza
    Salami, Marziyeh
    Gholinezhad, Yasaman
    Aghadavood, Farnaz
    Eshraghi, Reza
    Aarabi, Mohammad-Hossein
    Homayoonfal, Mina
    Asemi, Zatollah
    Mirzaei, Hamed
    Hajijafari, Mohammad
    Mafi, Alireza
    Rezaee, Malihe
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [29] Protective Effects of Thyroid Hormone Deprivation on Progression of Maladaptive Cardiac Hypertrophy and Heart Failure
    Kerp, Helena
    Hoenes, Georg Sebastian
    Tolstik, Elen
    Hoenes-Wendland, Judith
    Gassen, Janina
    Moeller, Lars Christian
    Lorenz, Kristina
    Fuehrer, Dagmar
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [30] Cyclosporin A inhibits cardiac hypertrophy and enhances cardiac dysfunction during postinfarction failure in rats
    Oie, E
    Bjornerheim, R
    Clausen, OPF
    Attramadal, H
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 278 (06): : H2115 - H2123